Manufacturer copay assistance · Monoferric (J1437) · Pharmacosmos
$0/dose · Maximum benefit Up to $4,000 per calendar year · Covers Monoferric drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Monoferric — the program's cap applies against the patient share CareCost calculates.
Yes — Monoferric Patient Solutions Co-pay Program from Pharmacosmos. Patient pays $0 per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $0 per dose Maximum benefit: Up to $4,000 per calendar year. Covers Monoferric drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.